Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 3616 AL 3630

Coordinated roles of SLX4 and MutSβ in DNA repair and the maintenance of genome stability

Young SJ, West SC.

Crit Rev Biochem Mol Biol. 2021 Apr;56(2):157-177. doi: 10.1080/10409238.2021.1881433. Epub 2021 Feb 17.

Cerebrospinal Fluid Markers of Medium Spiny Neuron Injury in Huntington's Disease

Bang J, Ross CA.

Mov Disord. 2021 Feb;36(2):280-282. doi: 10.1002/mds.28386.

Glucocorticoid impairs mitochondrial quality control in neurons

Choi GE, Han HJ.

Neurobiol Dis. 2021 May;152:105301. doi: 10.1016/j.nbd.2021.105301. Epub 2021 Feb 17.

Role of extracellular vesicles in neurodegenerative diseases

Xiao Y, Wang SK, Zhang Y, Rostami A, Kenkare A, Casella G, Yuan ZQ, Li X.

Prog Neurobiol. 2021 Jun;201:102022. doi: 10.1016/j.pneurobio.2021.102022. Epub 2021 Feb 19.

Entering a new era of quantifying glutamate clearance in health and disease

Brymer KJ, Barnes JR, Parsons MP.

J Neurosci Res. 2021 Jun;99(6):1598-1617. doi: 10.1002/jnr.24810. Epub 2021 Feb 22.

Amantadine: reappraisal of the timeless diamond-target updates and novel therapeutic potentials

Danysz W, Dekundy A, Scheschonka A, Riederer P.

J Neural Transm (Vienna). 2021 Feb;128(2):127-169. doi: 10.1007/s00702-021-02306-2. Epub 2021 Feb 23.

Ferroptosis and its potential as a therapeutic target

Yuan H, Pratte J, Giardina C.

Biochem Pharmacol. 2021 Apr;186:114486. doi: 10.1016/j.bcp.2021.114486. Epub 2021 Feb 23.

Benign Presentation Following Massive Deutetrabenazine Overdose

Obadeyi O, Paxton JH, Kouyoumjian S.

Cureus. 2021 Jan 24;13(1):e12886. doi: 10.7759/cureus.12886.

The bile acid TUDCA and neurodegenerative disorders: An overview

Zangerolamo L, Vettorazzi JF, Rosa LRO, Carneiro EM, Barbosa HCL.

Life Sci. 2021 May 1;272:119252. doi: 10.1016/j.lfs.2021.119252. Epub 2021 Feb 23.

Huntington disease-like phenotype in a patient with ANO3 mutation

Koya Kutty S, Mulroy E, Magrinelli F, Di Lazzaro G, Latorre A, Bhatia KP.

Parkinsonism Relat Disord. 2021 Sep;90:120-122. doi: 10.1016/j.parkreldis.2021.02.022. Epub 2021 Feb 20.

Proteolysis targeting chimera technology: a novel strategy for treating diseases of the central nervous system

Ma K, Han XX, Yang XM, Zhou SL.

Neural Regen Res. 2021 Oct;16(10):1944-1949. doi: 10.4103/1673-5374.308075.

D1R- and D2R-Medium-Sized Spiny Neurons Diversity: Insights Into Striatal Vulnerability to Huntington's Disease Mutation

Bergonzoni G, Döring J, Biagioli M.

Front Cell Neurosci. 2021 Feb 10;15:628010. doi: 10.3389/fncel.2021.628010. eCollection 2021.

Stem cell in neurodegenerative disorders; an emerging strategy

Ahani-Nahayati M, Shariati A, Mahmoodi M, Olegovna Zekiy A, Javidi K, Shamlou S, Mousakhani A, Zamani M, Hassanzadeh A.

Int J Dev Neurosci. 2021 Jun;81(4):291-311. doi: 10.1002/jdn.10101. Epub 2021 Mar 10.

PERK Pathway and Neurodegenerative Disease: To Inhibit or to Activate?

Shacham T, Patel C, Lederkremer GZ.

Biomolecules. 2021 Feb 26;11(3):354. doi: 10.3390/biom11030354.

Neuroacanthocytosis Syndromes in an Italian Cohort: Clinical Spectrum, High Genetic Variability and Muscle Involvement

Vaisfeld A, Bruno G, Petracca M, Bentivoglio AR, Servidei S, Vita MG, Bove F, Straccia G, Dato C, Di Iorio G, Sampaolo S, Peluso S, De Rosa A, De Michele G, Barghigiani M, Galatolo D, Tessa A, Santorelli F, Chiurazzi P, Melone MAB.

Genes (Basel). 2021 Feb 26;12(3):344. doi: 10.3390/genes12030344.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias